Nephrotic Syndrome

Overview

Overview Nephrotic syndrome is a relatively rare but important manifestation of kidney disease. Nephrotic syndrome classically presents with heavy proteinuria, minimal hematuria, hypoalbuminemia, hypercholesterolemia, edema, and hypertension. In general, all patients with hypercholesterolemia secondary to nephrotic syndrome should be treated with lipid-lowering agents because they are at increased risk for cardiovascular disease. Nephrotic syndrome has serious complications and must be part of the differential diagnosis for any patient presenting with new onset edema. All patients should be referred to a nephrologist for further investigation, which often include a renal biopsy.

Remember Classic tetrad of Nephrotic syndrome is proteinuria (>3g/24hr), hypoalbuminemia, hypercholesterolemia an oedema.
Glomerulonephritis

Glomerulonephritis is inflammation of the glomerulus. There are two broad types Nephritic glomerulonephritis and nephrotic glormerulonephritis

Remember Glomerulonephritis is divided into two broad groups:
  • Nephritic glomerulonephritis (Basement membrane/endothelium injury causing Haematuria)
  • Nephrotic glomerulonephritis (Podocyte injury causing proteinuria)

Nephrotic Syndrome

path

Nephrotic Glomerulonephritis is a renal condition affecting the podocytes. This causes a leaky glomeruli leading to proteinuria and subsequent hyperlipidemia, hypoalbuminemia and oedema

Classification

The page will focus on four common nephrotic syndromes towards the end:

  • Minimal Change Disease
  • Focal Segmental Disease
  • Membranous Glomerulonephritis
  • Diabetic Nephropathy
Side note Most common cause of chronic kidney disease and nephrotic syndrome is Diabetic nephropathy

Kidney and Glomerular Anatomy

The kidneys are retroperitoneal organs (at the back of abdomen) and lies between T11 and L3, the left kidney lying slightly higher than the right kidney.

The kidney is surrounding by an outer membrane called the renal capsule. The outer layer of the kidney is the renal cortex where most of the nephrons are situated. The inner layer is the renal medulla which contain renal pyramids. The renal pyramids drain urine into the minor - major calyces before draining to the renal pelvis then the ureter.

Arterial blood supply

  • Abdominal Aorta → Renal arteries
  • The renal artery branches into smaller and smaller arteries until finally becoming afferent arterioles which supply individual glomeruli
anatomy and physio

Anatomy Layers of the glomerulus

The Nephrons are the functional units of the kidney. There are millions. The nephron is made up of:

  • Bowman's capsule - afferent arteriole enters the bowmans capsule and forms t and efferent exits
  • Proximal convoluted tubule
  • Loop of Henle (descending and ascending)
  • Distal convoluted tubule
  • Collecting ducts

The glomerulus is a network of blood vessels that are located within the bowman's capsule. To understand the cause, pathophyiology and effect of glomerulonephritis it is important to learn the layers of the glomerulus + bowman's capsule

From inside out the layers are:

  • Endothelial cells of the blood vessels
  • Glomerular basement membrane
  • Podocytes
  • Bowman's space
  • Parietal cells.
  • In the center of the glomerulus are the mesangial cells which help in regulating blood flow the glomeruli.

Signs and Symptoms

Clinical Presentation

sands

Classic tetrad of nephrotic syndrome


Examination

Oedema

  • Periorbital oedema
  • Peripheral edema
  • Ascites

Hypoalbuminemia

  • Tiredness
  • Leuconychia

Dyslipidemia

  • Eruptive xanthomata
  • Xanthelasmata

Breathlessness with chest pain (Pulmonary Oedema and pleural effusion)

Frothy Urine

Differential Diagnosis

This section will mainly focus on the Primary Aetiology + Diabetic Nephropathy

Primary Aetiology of Nephrotic Syndrome

  • Minimal Change Disease
  • Membranous Glomerulonephritis
  • Focal Segmental Glomerulosclerosis

types of primary


Secondary Aetiology Nephrotic Syndrome

Other causes of bilateral swollen legs (because one of the classic presentations of nephrotic syndrome is oedema)

  • Heart failure
  • Lymphoedemea
  • Hypoalbuminaemia
  • Hepatic failure

Investigations

General

  • Urine Dipstick
  • Mid-Stream Urine - microscopy
  • Full blood count
  • EUC
  • LFT
  • Plasma Ca2+

Check for other systemic diseases and causes of nephrotic syndrome

  • CRP
  • Glucose
  • Serum Immunoglobulins
  • Urine Immunoglobulins
  • Autoimmune screen (ANA, dsDNA, C3, C4)
  • Hepatititis B & C
  • HIV

Chest Xray - if breathless (effusion)

Abdominal or renal ultrasound

Renal biopsy to perform microscopy, immunofluorescence and Electromicrography

Pathophysiology

path

Nephrotic Glomerulonephritis is a renal condition affecting the podocytes. This causes a leaky glomeruli leading to proteinuria and subsequent hyperlipidemia, hypoalbuminemia and oedema

Pathophysiology - General

Pathophysiology of Nephrotic Syndrome

 

Minimal Change Disease

Overview Minimal change disease (MCD), sometimes known as nil lesion, causes 70–90% of nephrotic syndrome in childhood but only 10–15% of nephrotic syndrome in adults. Minimal change disease usually presents as a primary renal disease but can be associated with several other conditions, including Hodgkin’s disease, allergies, or use of nonsteroidal anti-inflammatory agents.

Clinical Presentation

  • Children
  • Anorexia
  • GI disturbance
  • Infections
  • Irritability
  • Oedema (peritorbital, genital)
  • Ascites
  • Oliguria
Minimal Change Disease The most common presentation of MCNS is oedema. MCNS is characterised by oedema, selective proteinuria, hypoalbuminaeia, hypercholesterolaemia, and a normal glomerular filtration rate. Renal Biopsy: The only abnormality is diffuse effacement and fusion of epithelial cell fot processes.

Renal Biopsy

  • Light Microscopy: nil
  • Immunoflourescence: occasional IgG in the mesangium
  • Electron microscopy: consistently demonstrates an effacement of 177 the foot process supporting the epithelial podocytes with weakening of slit-pore membranes.

minial change

Management

  • Prednisone - First line
  • Cyclophosphamide - If steroid toxicity and relapsing nephrotic syndrome
Side note After initial treatment, proteinuria <0.3 g/day is defined as complete remission; a reduction of baseline proteinuria by >50% with a final value <3 g/day is defined as partial remission.
Remember 90% 0f patients experience a frequently relapsing or steroid-dependent course with steroid toxicity. These patients are candidates for treatment with second line drugs - cyclophosphamide or tacrolimus

Complications

  • Infections (including spontaneous peritonitis)
  • Thrombosis - due to haemoconcenration and loss of proteins such as antithrombin III, leading to a procoagulant state.
  • Hypovolaemia - due to loss of plasma water into the tissues with consequent fall in circulating blood volume.
  • Relapse of Minimal Change Disease in Adulthood
Side note Relapses occur in 70–75% of children after the first remission, and early relapse predicts multiple subsequent relapses

Focal Segmental Glomerulosclerosis

Focal segmental glomerulosclerosis (FSGS) refers to a pattern of renal injury characterised by segmental glomerular scars that involve some but not all glomeruli; the clinical findings of FSGS largely manifest as proteinuria. When the secondary causes of FSGS are eliminated, the remaining patients are considered to have primary FSGS.

Side note The incidence of this disease is increasing, and it now represents up to one-third of cases of nephrotic syndrome in adults

Renal Biopsy

  • Light Microsopy: focal and segmental glomerular sclerosis or consolidation
  • Immunoflorecence: usually show no staining for immunoglobulins or complement
  • Electron Microscopy:

focal segmental

Management

  • ACE inhibitors
  • Angiotensin II receptor blockers

Membranous Glomerulonephritis

Membranous glomerulonephritis (MGN), or membranous nephropathy, accounts for approximately 30% of cases of nephrotic syndrome in adults, with a peak incidence between the ages of 30 and 50 years and a male to female ratio of 2:1.

Remember Membranous glomerulonephritisis is rare in childhood and the most common cause of nephrotic syndrome in the elderly

Renal Biopsy

  • Light Microscopy: Diffuse global capillary wall thickening in the absence of significant glomerular hypercellularity
  • Electron Microscopy: Uniform thickening of the basement membrane along the peripheral capillary loops is seen by light microscopy on renal biopsy
  • Immunofluorescence demonstrates diffuse granular deposits of IgG and C3, and electron microscopy typically reveals electron-dense subepithelial deposits.

membranous

Diabetic Nephropathy

Overview Type II Diabetes Mellitus is the leading cause of Chronic Kidney Disease. It is classified as a secondary nephrotic syndrome. ~10% have nephropathy at diagnosis and up to half will go on to develop it over the next 20yrs. 20% of people with Type II diabetes will develop end stage kidney disease. Everyone with Diabetes should be screened yearly for microalbuminuria.

Clinical features - Nephrotic Syndrome with signs and symptoms of diabetes (hyperglycemia)

Pathological features Diabetic nephropathy is defined by characteristic structural and functional changes. The predominant structural changes include

  • Mesangial expansion
  • Glomerular basement membrane thickening
  • Glomerular sclerosis
  • Podocytopathy
Staging
Class I Isolated glomerular basement membrane thickening. There is no evidence of mesangial expansion, increased mesangial matrix, or global glomerulosclerosis involving >50 percent of glomeruli.
Class II Mild (class IIa) or severe (class IIb) mesangial expansion.
Class III At least one Kimmelstiel-Wilson lesion (nodular intercapillary glomerulosclerosis) is observed on biopsy and there is <50 percent global glomerulosclerosis.
Class IV Advanced diabetic sclerosis. There is >50 percent global glomerulosclerosis.
nephropahty

Pathogenesis

Management and Prognosis Microalbuminuria is reversible if caught early and managed vigorously.

  • Tight glycemic control
  • Right BP control with ACE/ARBs
  • Manage CV risk factors

More info on Chronic Kidney Disease

Complications Prognosis

Complications

References

UpToDate
Best Practice
Contents
cross